Noncompaction cardiomyopathy medical therapy
|
Noncompaction Cardiomyopathy Microchapters |
|
Pathophysiology |
|---|
|
Differentiating Noncompaction Cardiomyopathy from other Diseases |
|
Diagnosis |
|
Treatment |
|
Noncompaction cardiomyopathy medical therapy On the Web |
|
Risk calculators and risk factors for Noncompaction cardiomyopathy medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Overview
The management of NCC is similar to that of other cardiomyopathies and includes the use of ACE inhibitors, beta blockers and aspirin. Implantation of an automatic internal cardiac defibrillator AICD may be appropriate in patients who are deemed to be at increased risk of sudden cardiac death. A small study from the Netherlands identified young females with premature ventricular contractions (PVCs) at risk of sudden death[1].
In severe NCC cases, in which severe heart failure has developed, a heart transplant may be necessary.
Antiplatelet Therapy
Given the risk of embolization, these patients are generally treated with prophylactic aspirin.